Phenomenological Model of Laser-Tissue Interaction with Application to Benign Prostatic Hyperplasia (BPH) Simulation

被引:2
|
作者
Zhou, Xiangmin [1 ]
Zhang, Nan [1 ]
Shen, Yunhe [1 ]
Burke, Dan [1 ]
Konchada, Vamsi [1 ]
Sweet, Robert [1 ]
机构
[1] Univ Minnesota, CREST, Minneapolis, MN 55455 USA
来源
关键词
Laser tissue interaction; Phenomenological Model;
D O I
10.3233/978-1-60750-706-2-749
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Laser-tissue interaction is a multi-physics phenomenon not yet mathematically describable and computationally predictable. It is a challenge to model the laser-tissue interaction for real time laser Benign Prostatic Hyperplasia (BPH) simulation which requires the laser-tissue interaction model to be computationally efficient and accurate. Under the consideration and enforcement of the thermodynamic first law and treating the laser-tissue interaction as a gray-box, utilizing the sensitivity analysis of some key parameters that will affect the laser intensity on the tissue surface with respect to the tissue vaporization rate, a phenomenological model of laser-tissue interaction is developed. The developed laser-tissue interaction model has been implemented for a laser BPH simulator and achieves real time performance (more than 30 frames per second). The model agrees well with the available experimental data.
引用
收藏
页码:749 / 755
页数:7
相关论文
共 50 条
  • [21] NATURAL-HISTORY OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    SCHRODER, FH
    BLOM, JHM
    PROSTATE, 1989, : 17 - 22
  • [22] Risk stratification for benign prostatic hyperplasia (BPH) treatment
    Emberton, Mark
    Fitzpatrick, John M.
    Rees, Jon
    BJU INTERNATIONAL, 2011, 107 (06) : 876 - 880
  • [23] DECISIONAL QUALITY IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH)
    Shirk, Joseph
    Lambrechts, Sylvia
    Kwan, Lorna
    Munnangi, Meghana
    Sumal, Amit
    Saigal, Christopher
    JOURNAL OF UROLOGY, 2016, 195 (04): : E278 - E278
  • [24] URODYNAMICS (UDS) USAGE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    Thorogood, Samantha L.
    Zhang, Tenny R.
    Sze, Christina
    Strasser, Mary O.
    Demeo, Gina
    Lee, Richard K.
    Chughtai, Bilal
    Te, Alexis
    Hu, Jim C.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E303 - E304
  • [25] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [26] PRINCIPLES OF ENDOCRINE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
    ELETREBY, MF
    HABENICHT, UF
    ANTICANCER RESEARCH, 1986, 6 (03) : 391 - 392
  • [27] The role of inflammation in the etiopathogenesis of Benign Prostatic Hyperplasia (BPH)
    Tekin, Ali
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04): : 15 - 19
  • [28] Herbal medications in the treatment of benign prostatic hyperplasia (BPH)
    Fagelman, E
    Lowe, FC
    UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 23 - +
  • [29] ALPHA-BLOCKADE FOR BENIGN PROSTATIC HYPERPLASIA (BPH)
    LEPOR, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (03): : 750 - 753
  • [30] Macrophage infiltration of the stroma in benign prostatic hyperplasia (BPH)
    Gurski, L. A.
    Pascal, L. E.
    Nelson, J. B.
    Pilch, J.
    Wang, Z.
    MOLECULAR BIOLOGY OF THE CELL, 2014, 25